Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 6, 2004, Pages 1035-1043

  Do Couto, Bruno Ribeiro ^a   Aguilar, Maria A ^a   Manzanedo, Carmen ^b   Rodríguez Arias, Marta ^a   Miñrro, Jose ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

CPP (conditioned place preference); Memantine; MK 801; Morphine; Place conditioning

Indexed keywords

DIZOCILPINE; MEMANTINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; EXAMINATION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; REINFORCEMENT; REWARD;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMANTINE; MICE; MORPHINE; NARCOTICS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 4544308833     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.05.038     Document Type: Article

References (87)

1. R.L. Albin, R.L. Makowiec, Z.R. Hollingsworth, L.S. Dure, J.B. Penney, and A.B. Young Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study Neuroscience 46 1991 35 48
2. Areosa, S.A., Sherriff, F., 2003. Memantine for dementia, Cochrane Database Syst Rev. 1:CD003154.
3. P.M. Beardsley, B.A. Hayes, and R.L. Balster The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys J. Pharmacol. Exp. Ther. 252 1990 953 959
4. G. Biala, and J. Kotlinska Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-d-aspartate receptor antagonists Alcohol Alcohol. 34 2 1999 175 182
5. A. Bisaga, S.D. Comer, A.S. Ward, P. Popik, H.D. Kleber, and M.W. Flischman The NMDA antagonist memantine attenuates the expression on opioid physical dependence in humans Psychopharmacology 157 1 2001 1 10
6. J. Borman Memantine is a potent blocker of N-methyl-d-aspartate (NMDA) receptor channels Eur. J. Pharmacol. 166 1989 591 592
7. I. Bresink, W. Danysz, C.G. Parssons, and E. Mutschler Different binding affinities of NMDA receptor channel blocker in various brain regionsâ€"indication of NMDA receptor heterogeneity Neuropharmacology 34 5 1995 533 540
8. M. Bubser, U. Keseberg, P.K. Notz, and W.J. Schmidt Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists rats Eur. J. Pharmacol. 229 1 1992 75 82
9. M.J. Cano-Cebrian, T. Zornoza-Sabina, C. Guerri, A. Polache, and L. Granero Local acamprosate modulates dopamine release in the rat nucleus accumbens through NMDA receptors: an in vivo microdialysis study Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2 2003 119 125
10. W.A. Carlezon Jr., and R.A. Wise Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801 Brain Res. 620 2 1993 339 342
11. W.A. Carlezon Jr., T.A. Kosten, and E.J. Nestler Behavioral interactions caused by combined administration of morphine and MK-801 in rats Psychopharmacology 151 2â€"3 2000 261 272
12. C.J. Carter Topographical distribution of possible glutamatergic pathways from the cortex to the striatum and substantia nigra in rats Neuropharmacology 21 1982 379 383
13. M.F. Christie, S. Bridge, L.B. James, and P.M. Beart Excitotoxin lesions suggest an aspartatergic projections from rat medial prefrontal cortex to ventral tegmental area Acta Physiol. Scand. 136 1989 135 136
14. H.W. Clement, C. Grote, L. Svensson, J. Engel, P. Zofel, and W. Wesemann In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat J. Neural. Transm., Suppl. 46 1995 107 115
15. E.D. Collins, A.S. Ward, D.M. McDowell, R.W. Foltin, and M.W. Fischman The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans Behav. Pharmacol. 9 7 1998 587 598
16. D. Corbett Possible abuse potential of NMDA antagonist MK-801 Behav. Brain Res. 34 1989 239 246
17. C.W. Cotman, D.T. Monaghan, O.P. Ottersen, and J. Storm-Mathisen Anatomical organization of excitatory amino acid receptors and their pathways Trends Neurosci. 10 1987 273 279
18. W. Danysz, and C.G. Parsons Glycine and N-methyl-d-aspartate receptors: physiological significance and possible therapeutic applications Pharmacol. Rev. 50 1998 597 664
19. W. Danysz, C.G. Parsons, and G. Quack NMDA channel blockers: memantine and amino-aklylcyclohexanesâ€"in vivo characterization Amino Acids 19 2000 167 172
20. E. Del Pozo, M. Barrios, and J.M. Baeyens The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice Psychopharmacology 125 1996 209 213
21. T.A. Fuller, F.T. Russchen, and J.L. Price Sources of presumptive glutamatergic/aspartergic afferents to the rat ventral striatopallidal region J. Comp. Neurol. 258 1987 317 338
22. F. Georges, and G. Aston-Jones Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons J. Neurosci. 22 12 2002 5173 5187
23. A.J. Goudie Animal models of drug abuse and dependence P. Wilner Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives 1991 Cambridge Univ. Press Cambridge 453 484
24. K.A. Grant, G. Colombo, J. Grant, and M.A. Rogawski Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists Neuropharmacology 35 12 1996 11709 11719
25. M.B. Hesselink, A.G. De Boer, D.D. Breimer, and W. Danysz Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: a microdialysis study in rats J. Neural. Transm. 106 9â€"10 1999 803 818
26. D.C. Hoffman The non-competitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats Pharmacol. Biochem. Behav. 47 1994 907 912
27. P. Hyytia, P. Backstrom, and S. Liljequist Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats Eur. J. Pharmacol. 378 1 1999 9 16
28. S.W. Johnson, and R.A. North Opioids excite dopamine neurons by hyperpolarization of local interneurons J. Neurosci. 12 1992 483 488
29. P.W. Kalivas, and J.E. Alsdatter Involvement of N-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine J. Pharmacol. Exp. Ther. 267 1993 486 495
30. P.W. Kalivas, P. Duffy, and J. Barrow Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes J. Pharmacol. Exp. Ther. 251 1 1989 378 387
31. M. Karreman, B.H. Westerink, and B. Moghaddam Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum J. Neurochem. 67 2 1996 601 607
32. A.E. Kelley, V.B. Domesick, and W.J.H. Nauta The amygdalostriatal projection in the ratâ€"an anatomical study by anterograde and retrograde tracing methods Neuroscience 7 1982 615 626
33. G.J. Kilpatrick, and G.S. Tilbrook Memantine Merz. Curr. Opin. Investig. Drugs 3 5 2002 798 806
34. H.S. Kim, C.G. Jang, and W. Park Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice Pharmacol. Biochem. Behav. 55 1996 11 17
35. H. Kita, and S.T. Kitai Efferent projections of subthalamic nucleus in the rat. Light and electron microscopic analysis with the PHA-L method J. Comp. Neurol. 372 1986 21 30
36. W. Koek, F.C. Colpaert, J.H. Woods, and J.M. Kamenka The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801 J. Pharmacol. Exp. Ther. 250 3 1989 1019 1027
37. J. Kotlinska, and G. Biala Effects of the NMDA/glycine receptor antagonist, L-701,324, on morphine- and cocaine-induced place preference Pol. J. Pharmacol. 51 4 1999 323 330
38. J. Kotlinska, and G. Biala Memantine and ACPC affect conditioned place preference induced by cocaine in rats Pol. J. Pharmacol. 52 3 2000 179 185
39. B.D. Kretschmer Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors J. Neurochem. 73 2 1999 839 848
40. R.T. Layer, F.G. Kadis, and L.J. Wallace The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats Pharmacol. Biochem. Behav. 44 1993 245 247
41. P. Leone, D. Pocock, and R.A. Wise Morphineâ€"dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release Pharmacol. Biochem. Behav. 39 1991 469 472
42. M.S. Levi, and R.F. Borne A review of chemical agents in the pharmacotherapy of addiction Curr. Med. Chem. 9 20 2002 1807 1818
43. C. Maldonado, O. Cauli, M. Rodríguez-Arias, M.A. Aguilar, and J. Miñarro Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal Behav. Brain Res. 144 2003 25 35
44. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Conditioned place preference can be a mouse model of relapse to opiates Neurosci. Res. Commun. 28 2001 23 29
45. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice Behav. Brain Res. 121 2001 189 197
46. C. Manzanedo, A. Serrano, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Effects of CGS 10746B on morphine-induced hyperactivity and place preference Behav. Brain Res. 126 2001 23 32
47. W.J. McBride, J.M. Murphy, and S. Ikemoto Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies Behav. Brain Res. 101 2 1999 129 152
48. D.T. Monaghan, and C.W. Cotman Distribution of N-methyl-d-aspartate- sensitive l-[3H]glutamate-binding sites in rat brain J. Neurosci. 5 1985 2909 2919
49. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat. Rev. Neurosci. 2 2001 119 128
50. K.L. Nicholson, H.E. Jones, and R.L. Balster Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-d-aspartate channel blocker memantine Behav. Pharmacol. 9 3 1998 231 243
51. M.C. Olmstead, and KB. Franklin The development of a conditioned place preference to morphine: effects of lesions of various CNS sites Behav. Neurosci. 111 6 1997 1313 1323
52. M.C. Olmstead, and K.B. Franklin The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites Behav. Neurosci. 111 6 1997 1324 1334
53. J.J. Panos, D.J. Rademacher, S.L. Renner, and R.E. Steinpreis The rewarding properties of NMDA and MK-801 (dizocilpine) as indexed by the conditioned place preference paradigm Pharmacol. Biochem. Behav. 64 1999 591 595
54. M. Papp, and E. Moryl Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats Pol. J. Pharmacol. 46 1994 79 81
55. M. Papp, E. Moryl, and M.L. Maccechini Differential effects of agents acting at various sites of the NMDA receptor complex in a place conditioning model Eur. J. Pharmacol. 317 1996 191 196
56. M. Papp, P. Gruca, and P. Willner Selective blockade of drug-induced place preference conditioning by ACPC, a functional NMDA-receptor antagonist Neuropsychopharmacology 27 5 2002 727 743
57. C.G. Parsons, R. Gruner, J. Rozental, J. Millar, and D. Lodge Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan) Neuropharmacology 32 1993 1337 1350
58. C.G. Parsons, W. Danysz, and G. Quack Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonistâ€"a review of preclinical data Neuropharmacology 38 1999 735 767
59. C.G. Parsons, W. Danysz, and G. Quack Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are, moderate affinity uncompetitive NMDA receptor antagonists in vitro characterization Amino Acids 19 2000 157 166
60. P. Popik, and W. Danysz Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-d-aspartate receptor antagonist, memantine J. Pharmacol. Exp. Ther. 280 1997 854 865
61. P. Popik, and W. Kolasiewicz Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward Naunyn-Schmiedeberg's Arch. Pharmacol. 359 1999 288 294
62. P. Popik, and P. Skolnick The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence Pharmacol. Biochem. Behav. 53 1996 791 798
63. P. Popik, and M. Wrobel Morphine conditioned reward is inhibited by MPEP, the mGluR5antagonist Neuropharmacology 43 8 2002 1210 1217
64. P. Popik, J. Mamczarz, M. Fraczek, M. Widla, M. Hesselink, and W. Danysz Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists Neuropharmacology 37 1998 1033 1042
65. P. Popik, E. Kozela, M. Wrobel, K.M. Wozniak, and B.S. Slusher Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate Carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA Neuropsychopharmacology 28 3 2003 457 467
66. R.H. Porter, and J.T. Greenamyre Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential J. Neurochem. 64 2 1995 614 623
67. G. Quack, M. Hesselink, W. Danysz, and R. Spanagel Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover J. Neural. Transm., Suppl. 46 1995 97 105
68. T.G. Robinson, and P.M. Beart Excitant amino acid projections from rat amygdala and thalamus to nucleus accumbens Brain Res. Bull. 20 1988 467 471
69. S. Semenova, W. Danysz, and A. Bespalov Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice Eur. J. Pharmacol. 378 1999 1 8
70. R. Spanagel, B. Eilbacher, and R. Wilke Memantine-induced dopamine release in the prefrontal cortex and striatum of the ratâ€"a pharmacokinetic microdialysis study Eur. J. Pharmacol. 262 1â€"2 1994 21 26
71. R.E. Steinpreis, M.A. Kramer, K.S. Mix, and M.C. Piwowarczyk The effects of MK-801 on place conditioning Neurosci. Res. 22 1995 427 430
72. I. Sukhotina, O. Dravolina, and A. Bespalov Place conditioning of mice with NMDA receptor antagonists, elipordil and dizocilpine Eur. J. Pharmacol. 362 1998 103 110
73. T. Suzuki, T. Aoki, H. Kato, M. Yamazaki, and M. Misawa Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preference in mice Eur. J. Pharmacol. 385 2â€"3 1999 99 102
74. T. Suzuki, H. Kato, T. Aoki, M. Tsuda, M. Narita, and M. Misawa Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice Life Sci. 67 4 2000 383 389
75. T.M. Tzschentke, and J. Schmidt N-methyl-d-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats Neurosci. 193 1995 37 40
76. T.M. Tzschentke, and W.J. Schmidt Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitisation Behav. Brain Res. 84 1997 99 107
77. T.M. Tzschentke, and W.J. Schmidt Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole Neurosci. Lett. 242 2 1998 114 116
78. T.M. Tzschentke, and W.J. Schmidt Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm Behav. Brain Res. 98 11â€"2 1998 115 127
79. T.M. Tzschentke, and J. Schmidt Memantine does not substantially affect brain stimulation reward: comparison with MK-801 Brain Res. 845 1999 192 198
80. T.M. Tzschentke, and W.J. Schmidt Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward Psychopharmacology 149 2000 225 234
81. J. Vetulani Drug addiction: Part III. Pharmacotherapy of addiction Pol. J. Pharmacol. 53 5 2001 415 434
82. I. Walaas Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudatoputamen in the rat brain Neuroscience 6 1981 399 405
83. I. Walaas, and F. Fonnum The effects of surgical and chemical lesions on neurotransmitter candidates in the nucleus accumbens of the rat Neuroscience 4 1979 209 216
84. T. Watanabe, T. Nakagawa, R. Yamamoto, A. Maeda, M. Minami, and M. Satoh Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats Jpn. J. Pharmacol. 88 4 2002 399 406
85. R.A. Wise Drug-activation of brain reward pathways Drug Alcohol Depend. 51 1â€"2 1998 13 22
86. R.A. Wise Brain reward circuitry: insights unsensed incentives Neuron 36 2 2002 229 240
87. Z.X. Xi, and E.A. Stein Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat Psychopharmacology 164 2 2002 144 150